You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 164 No. 6, March 22, 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Viral Infections
 •Diagnosis
 •Emergency Medicine
 •Alert me on articles by topic

Differentiating Inhalational Anthrax From Other Influenzalike Illnesses in the Setting of a National or Regional Anthrax Outbreak

Sandro K. Cinti, MD; Louis Saravolatz, MD; Daniel Nafziger, MD; James Sunstrum, MD; Gerald Blackburn, DO

Arch Intern Med. 2004;164:674-676.

The workup of a febrile patient who presents with an influenzalike illness in the setting of a national or regional anthrax outbreak presents a unique challenge to the physicians who initially evaluate this patient, and the diagnostic challenge can be even more profound during the influenza season. Based on information gathered from the recent inhalational anthrax cases, we have developed an algorithm to be used by physicians in the emergency department to evaluate patients with influenzalike illnesses during a national or regional anthrax outbreak. The algorithm necessitates stays no longer than 24 hours in the emergency department or hospital.


From the Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical Center/Ann Arbor VA Medical Center, Ann Arbor (Dr Cinti); Department of Internal Medicine, St John's Hospital, Detroit, Mich (Dr Saravolatz); Division of Infectious Diseases and Quality Support Services, Henry Ford Health System, Detroit (Dr Nafzinger); Division of Infectious Diseases, Oakwood Hospital, Oakwood, Mich (Dr Sunstrum); and Division of Infectious Diseases, Botsford Health Care Continuum, Farmington Hills, Mich (Dr Blackburn). The authors have no relevant financial interest in this article.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The cost-effectiveness of strategies to reduce mortality from an intentional release of aerosolized anthrax spores.
Braithwaite et al.
Med Decis Making 2006;26:182-193.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.